Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls
Xiaofen Zhang(World Wide Web Consortium), Quancheng Kan(Zhengzhou University), Zhicheng Du(Sun Yat-sen University), Zipeng Wang(Tongji University), Ziyao Yang(First Affiliated Hospital of Zhengzhou University), Wenlong Zhai(Zhengzhou University), Cai Li(Zhengzhou University), Yiding Zhang(National Institutes for Quantum Science and Technology), Ji Zhang(Zhengzhou University), Zijia Zhu(First Affiliated Hospital of Zhengzhou University), Ziyu Shi(First Affiliated Hospital of Zhengzhou University), Xin Tian(First Affiliated Hospital of Henan University), Zhenrui Jiao(Zhengzhou University)
The Journal of Steroid Biochemistry and Molecular Biology
October 28, 2020
Cited by 38
Related Papers
Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer
|Molecular Cancer|2022|652
Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment
|Nature Nanotechnology|2024|148
MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis
|Journal of Experimental & Clinical Cancer Research|2020|139
Lung adenocarcinoma-intrinsic GBE1 signaling inhibits anti-tumor immunity
|Molecular Cancer|2019|84
Matrine induces cell cycle arrest and apoptosis with recovery of the expression of miR-126 in the A549 non-small cell lung cancer cell line
|Molecular Medicine Reports|2016|78